Institute at St. David’s. Photo: Alex Wang
When patients are diagnosed with glioblastoma, one of the worst forms of brain cancer, their options are limited.
Even after surgically accessing the brain to remove as much of the tumor as possible and applying intense chemotherapy, the prognosis is poor. The average survival time is about 14 months.
“There are really no good treatments,” said Vishy Iyer, a professor of molecular genetics and microbiology in the College of Natural Sciences at The University of Texas at Austin, who is trying to change that.
“You can do surgery and chemotherapy, but glioblastoma is just bad to have.”
Kaine Korzekwa — Science Communicator 